SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-23-000025
Filing Date
2023-05-04
Accepted
2023-05-04 16:07:30
Documents
57
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q abus-20230331.htm   iXBRL 10-Q 1066737
2 EX-31.1 a2023-q110xqex311.htm EX-31.1 10909
3 EX-31.2 a2023-q110xqex312.htm EX-31.2 10927
4 EX-32.1 a2023-q110xqex321.htm EX-32.1 4930
5 EX-32.2 a2023-q110xqex322.htm EX-32.2 4960
11 PIPELINE abus-20230331_g1.jpg GRAPHIC 134610
  Complete submission text file 0001447028-23-000025.txt   5481561

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20230331.xsd EX-101.SCH 38317
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20230331_cal.xml EX-101.CAL 45016
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20230331_def.xml EX-101.DEF 174686
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20230331_lab.xml EX-101.LAB 432407
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20230331_pre.xml EX-101.PRE 282453
51 EXTRACTED XBRL INSTANCE DOCUMENT abus-20230331_htm.xml XML 810372
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 23888681
SIC: 2834 Pharmaceutical Preparations